Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Total article views   HTML views PDF downloads Totals
6,970 Dovepress* 6,508+ 418 6,926
PubMed Central* 462 187 649
Totals 6,970 605 7,575
*Since 1 March 2022

View citations on PubMed Central and Google Scholar